Thought Leadership
Article | September 14, 2016
Read more
An End-Run Around Myriad And 'Product Of Nature' Problem
Law360
Blog | September 06, 2016
D.Ariz excludes expert for not apportioning the rate, but OKs entire product as base
Fish & Richardson
Read more
Blog | August 27, 2016
Medical Diagnostic Tests — Are They Patentable? Don't Count On It.
Fish & Richardson
Read more
Blog | August 25, 2016
DDE excludes settlement agreements; allows licenses as a "check"; addresses apportionment of accused products & services
Fish & Richardson
Read more
Blog | August 19, 2016
SDFL allows opinion based in part on plaintiff's licensing proposals (or offers)
Fish & Richardson
Read more
Blog | August 17, 2016
EDTX questions viability of "inexorable flow" doctrine of lost profits
Fish & Richardson
Read more
Blog | August 16, 2016
Federal Circuit Once Again Finds That a Functional Claim Term is Indefinite Even Without the Use of "Means."
Fish & Richardson
Read more
Blog | August 15, 2016
NDCA excludes expert testimony for failure to apportion (including addressing claim scope argument)
Fish & Richardson
Read more
Blog | August 11, 2016
WDWI rejects "inexorable flow" doctrine of lost profits
Fish & Richardson
Read more
Blog | August 08, 2016
D. Mass. denies SJ where settlement licensees failed to mark
Fish & Richardson
Read more
Blog | August 01, 2016
Final FDA Guidance on "Low Risk Wellness" Products Adopts Novel Approach for Exempting Devices From Regulation
Fish & Richardson
Read more